Abstract
Individuals with serious mental illness (SMI) face a disproportionately high risk of cardiovascular disease (CVD) and premature mortality. This study evaluates a multi-faceted care management intervention—combining health coaches and nurses—designed to improve cholesterol management in this population. Through a secondary analysis of an 18-month randomized controlled trial (N=216), the study found that the intervention significantly reduced LDL cholesterol (LDL-C) levels compared to usual care. The most substantial improvements were linked to medication intensifications facilitated by nurse advocacy during primary care visits, highlighting the critical role of clinical coordination in bridging the gap between psychiatric and primary care.
Introduction
Individuals with serious mental illness (SMI), such as schizophrenia or bipolar disorder, often die significantly earlier than the general population, primarily due to cardiovascular disease. Despite this high risk, they are less likely to receive standard-of-care management for CVD risk factors like dyslipidemia. Barriers include patient-level factors like executive dysfunction and systemic issues such as fragmented care. This paper evaluates whether a dedicated care management program, utilizing a "tag-team" approach of health coaches and nurses, can effectively lower LDL cholesterol (LDL-C) levels in individuals with SMI.
Methods
This study is a secondary analysis of data from an 18-month randomized controlled trial conducted across four outpatient psychiatric rehabilitation programs. The analysis included 216 adults with SMI who met clinical criteria for cholesterol management, such as existing dyslipidemia, diabetes, or high 10-year cardiovascular risk.
Participants were randomized into two groups:
- Intervention Group: Received support from health coaches for lifestyle goals (diet and exercise) and nurses for care coordination. Nurses accompanied patients to primary care provider (PCP) visits to advocate for evidence-based treatments.
- Control Group: Received "usual care," navigating the healthcare system independently.
The primary outcome was the change in low-density lipoprotein cholesterol (LDL-C) levels over 18 months. Process measures included the frequency of medication intensification (statin therapy changes) and the number of sessions with the intervention team.
Results
The intervention group showed a significantly greater reduction in LDL-C over 18 months compared to the control group (-11.7 mg/dl vs. -3.0 mg/dl, p=0.046). A key finding was the impact of medication intensification. Approximately 26% of the intervention group received a medication change, compared to 16% in the control group.
As shown in Table 1, intervention participants who received medication changes experienced a substantial LDL-C reduction of -24.0 mg/dl. These participants also had significantly more nurse-led clinic visits (mean 3.3) compared to those in the intervention group who did not receive medication changes (mean 1.2). This suggests that the presence of a clinical advocate (the nurse) at PCP visits was a primary driver for medication adjustments. Interestingly, medication changes in the control group did not result in significant LDL-C drops, suggesting the intervention also supported medication adherence through ongoing coaching.
Discussion
The results demonstrate that a coordinated care management approach can effectively address cardiovascular risk in the SMI population. The role of clinical advocacy appears central; having a nurse present during primary care visits helps overcome provider inertia and communication barriers. While lifestyle coaching is valuable, the most dramatic clinical improvements were driven by medication adjustments and the support needed to adhere to them.
Limitations of the study include its nature as a secondary analysis with relatively small subgroup sizes and the lack of direct observation of PCP interactions. Furthermore, the resource-intensive nature of providing both a nurse and a health coach poses challenges for scalability. Future research should investigate whether similar outcomes can be achieved through lower-cost digital tools or population health prompts in community settings.
Conclusion
A multi-faceted care management intervention significantly improves cholesterol control for individuals with SMI. The integration of clinical advocacy into primary care visits appears to be a crucial component in ensuring high-risk patients receive and adhere to necessary pharmacological treatments.
Summary updated